Web Results

TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC

www.leagle.com/decision/1995235234Conn1_1235/TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

ANUSHAVAN G. TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. PETERS, C. J. The principal issue in this appeal is whether there was ...

Opinion - Federal Trade Commission

www.ftc.gov/system/files/documents/cases/150220boehringeropinion.pdf

Feb 20, 2015 ... See FTC v. Boehringer Ingelheim Pharm., Inc., 286 F.R.D. 101 (D.D.C.. 2012). ... patented pharmaceutical drugs that earn hundreds of millions of dollars in .... FTC v. Grolier Inc., 462 U.S. 19, 27-28 (1983); In re Murphy,. 560 F.2d ... omitted); accord 8 CHARLES ALAN WRIGHT ET AL., FEDERAL. PRACTICE ...

Differential Effects of Teriparatide and Denosumab on Intact PTH ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4880160/

Feb 10, 2016 ... Medical writing support was provided by Lori Kornberg (INC Research ... and is a consultant for Merck, Tarsa Pharmaceuticals, and Radius Health. ... from Amgen, Boehringer Ingelheim, Immunodiagnostics, Lilly, Merck, ... Cummings SR, San Martin J, McClung MR, et al. .... Ma YL, Zeng Q, Donley DW, et al.

A Randomized, Controlled, Pilot Study of Acamprosate Added to ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3794470/

Comparisons between treatment arms (acamprosate vs placebo) were made by the .... Tiihonen et al found similar benefit in 62 alcoholic patients. ... served in advisory/consultative relationships with Boehringer Ingelheim and Pfizer. ... Inc, Transcept Pharmaceuticals, Vanda Pharmaceuticals Inc, Wyeth-Ayerst Laboratories.

Opposing Effects of PKCθ and WASp on Symmetry Breaking and ...

www.sciencedirect.com/science/article/pii/S0092867407004539

May 17, 2007 ... We imaged T cell dynamics in the DC-rich spleen (Kraal et al., 1986), ..... #20) was kindly provided by Boehringer-Ingelheim Pharmaceuticals, Inc. (Cywin et al., 2007). ... A-11018), donkey anti-sheep IgG (Molecular Probes, A-21099), or avidin ... We thank M. Nussenzweig for the CD11c<sup>+</sup>-YFP mice; and V.

Effectiveness and safety of different azacitidine dosage regimens in ...

www.sciencedirect.com/science/article/pii/S0145212614000666

AZA 5-2-2, p = 0.0021; AZA 5 vs. AZA 7, p ... Table 3. Assigned scores in lower- risk patients based on the prognostic score described by Garcia-Manero et al.

Anti-infective immunoadhesins from plants - Wycoff - 2015 - Plant ...

onlinelibrary.wiley.com/doi/10.1111/pbi.12441/full

Aug 4, 2015 ... It appears that Boehringer Ingelheim abandoned development of sICAM-1 as a .... The variants with V and LAPG at the N-terminus had the longest ... Following the 2001 anthrax attack (Borio et al., 2001; Jernigan et al., 2001, ..... goat anti- DPP4 IgG and reported with donkey anti-goat IgG labelled with HRP.

TDP-43 is intercellularly transmitted across axon terminals

jcb.rupress.org/content/211/4/897.full

Nov 23, 2015 ... S1, C and D; Chernyshev et al., 2015). ..... (1:500; 10782-2-AP; Proteintech Group, Inc.), mouse anti–TIA-1 related protein (TIAR; 1:500; BD), ... Thermo Fisher Scientific), and donkey anti–mouse IgG Alexa Fluor 647 (1:750; A31571; .... B. Strobel is an employee of Boehringer Ingelheim Pharma GmbH & Co.

Examination of Several Potential Mechanisms for the Negative ...

stroke.ahajournals.org/content/32/11/2665.full

E-selectin, endothelial P-selectin, and ICAM-1 were stained as described by Okada et al, with ... Biotinylated F(ab′)2 fragment of donkey anti-mouse IgG was used as the .... Main time effect (30 minutes vs 1 hour vs 2 hours) was also significant .... PhD, is employed by Boehringer Ingelheim Pharmaceuticals, Inc, which has ...

The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal ...

diabetes.diabetesjournals.org/content/62/4/1289

In the first set of experiments, 21 8-week-old mice were exposed to a high-fat diet (HFD; Research Diets, Inc., New ... Before the start of the linagliptin (Boehringer Ingelheim Pharma GmbH & Co. .... buffer containing 3% normal donkey serum and 0.25% Triton-X. The sections ..... Darsalia V,; Mansouri S,; Ortsäter H,; et al.

More Info

Boehringer Ingelheim Pharmaceuticals, Inc. | Federal Trade ...

www.ftc.gov

Feb 20, 2015 ... application/pdf icon FTC v. Boehringer Ingelheim Pharmaceuticals, Inc. (D.C. Cir. ), Response of FTC to Petition for Rehearing En Banc (113.12 ...

Evaluation of the Use of Inhaled Medications by Hospital Inpatients ...

www.ncbi.nlm.nih.gov

Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, et al. ... Spiriva® [ package insert] Ridgefield (CT): Boehringer Ingelheim Pharmaceuticals, Inc; 2011. ... observer agreement: a subjective assessment of working donkey behaviour ...

Expression and activation of Ephexin is altered after spinal cord injury

www.ncbi.nlm.nih.gov

2004) and modulation of pain in the spinal cord (Battaglia, Sehayek et al. 2003). ... Center, NY; 0.85 mg/kg) and xylazine (Boehringer Ingelheim, Ridgefield, CT; 4.2 mg/kg). ... Buprenex® (buprenorphine; Reckett & Colman Pharmaceuticals, Inc. .... solution and then HRP-conjugated donkey anti-rabbit IgG (1:10,000; Sigma, ...